XTLB — X T L Biopharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for X T L Biopharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	C2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	20-F	20-F	20-F	20-F	20-F
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	6.04	6.13	3.72	2.01	1.14
Net Total Accounts Receivable
Net Total Receivables	0.013	0.016	0.014	—	0.099
Prepaid Expenses
Total Current Assets	6.12	6.24	3.81	2.05	1.34
Net Property, Plant And Equipment	0.002	0.001	0	—	0.187
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	6.5	6.62	4.19	2.43	8.55
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.254	0.231	0.187	0.206	2.21
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	2.89	1.28	0.187	0.206	3.12
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	3.61	5.33	4	2.22	5.43
Total Liabilities & Shareholders' Equity	6.5	6.62	4.19	2.43	8.55
Total Common Shares Outstanding